Gian Life Care (BOM:542918) EBIT : ₹58.8 Mil (TTM As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Gian Life Care EBIT?

Gian Life Care's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was ₹2.7 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹58.8 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Gian Life Care's annualized ROC % for the quarter that ended in Sep. 2024 was 1.23%. Gian Life Care's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 21.53%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Gian Life Care's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 24.19%.

Gian Life Care EBIT Historical Data

The historical data trend for Gian Life Care's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gian Life Care EBIT Chart

Gian Life Care Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT

Get a 7-Day Free Trial

18.57

30.57

62.00

20.18

62.11

Gian Life Care Quarterly Data
	Jun19	Sep19	Mar20	Sep20	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT	Get a 7-Day Free Trial													3.47	22.20	31.18	2.75	2.68

Competitive Comparison of Gian Life Care's EBIT

For the Diagnostics & Research subindustry, Gian Life Care's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gian Life Care's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Gian Life Care's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Gian Life Care's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Gian Life Care EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹58.8 Mil.

Gian Life Care (BOM:542918) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Gian Life Care's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

	ROC % (Q: Sep. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2024 )	+	Invested Capital (Q: Sep. 2024 ))	/ count )
=	4.076 * ( 1 - 17.97% )	/	( (0	+	270.74)	/ 1 )
=	3.3435428	/	270.74
=	1.23 %

where

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0	-	0	-	( 0	-	max(0, 0	-	0	+	0	))
=	0

	Invested Capital		(Q: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	343.461	-	32.949	-	( 76.781	-	max(0, 115.968	-	155.74	+	76.781	))
=	270.74

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Gian Life Care's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2024		Q: Sep. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	10.712	/	( ( (0 + max(0, 0))	+	(49.743 + max(-11.589, 0)) )	/	1 )
=	10.712	/	( ( 0	+	49.743 )	/	1 )
=	10.712	/	49.743
=	21.53 %

where Working Capital is:

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0	+	0	+	0)
=	0

	Working Capital		(Q: Sep. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(55.152	+	5.843	+	17.964)	-	(32.949	+	0	+	57.599)
=	-11.589

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Gian Life Care's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2024 )
	=	58.801	/	243.109
	=	24.19 %

Gian Life Care EBIT Related Terms

Thank you for viewing the detailed overview of Gian Life Care's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Gian Life Care Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Gian Life Care Ltd (BOM:542918) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

7/216 (6) Swaroop Nagar, Infront of L-L.R. Hospital, Kanpur, UP, IND, 208002

Website

https://www.gianlifecare.org

Gian Life Care Ltd is an Indian firm engaged in the business of providing diagnostic and related healthcare tests and services in Kanpur and nearby areas. The company provides a broad range of diagnostic and related healthcare tests and services such as patient diagnosis, prevention, and wellness diagnosis services to its patients and healthcare providers. Its customers include individual patients, hospitals, other healthcare providers, and corporate customers. Substantial revenue accrues from the Pathological Testing Fees. The Company has only one operating segment namely, Laboratories Pathological Investigations.

Gian Life Care Headlines

No Headlines